Exagen (XGN) Precio de Acción, Cotización, Noticias e Historial | Benzinga

Exagen Inc (XGN) Precio de Acción, Cotización, Noticias e Historial

XGNNASDAQ

Trade with Public

Trade with Public

$7.73

0.010.13%

Últ. Act.: Oct 19, 9:30 AM

$7.73

0.010.13%

Panorámica generalNoticias Previsión de beneficios Eventos Precios objetivo Finanzas Sentimiento Propiedad Comparar Opciones Informe de acciones

© 2026 Benzinga | All Rights Reserved

Estadísticas Clave

Apertura

$7.72

Cierre

-

Volumen / Prom.

267.31K / 339.62K

Rango diario

$7.46 - $8.00

Rango de 52 semanas

2.59 - 12.23

Capitalización bursátil

$186.76M

Ratio PER

-

Rentabilidad por dividendo

-

Exchange

NASDAQ

RSI

55

Interés en corto

3.22%

Días para cubrir

2.46

Noticias Recientes de Exagen Inc.

Booking Holdings To Rally Around 12%? Here Are 10 Top Analyst Forecasts For Monday

Avi Kapoor

Time to Play 5 Top-Ranked Stocks With Rising P/E?

Wall Street has been hovering around a record high level, which can trigger overvaluation concerns in some investors' minds. This is because investors often opt for the stock-picking approach that involves stocks with a low price-to-earnings (P/E) ratio.

Zacks

Nike, Tencent Music Entertainment And 3 Stocks To Watch Heading Into Tuesday

With US futures trading higher this morning on Tuesday, some of the stocks that may grab investor focus today are as follows:

Lisa Levin

Partner Content

Coya Therapeutics' Expansion Of Exclusive Worldwide Licensing Agreement With ARscience Biotherapeutics Could Have Outsized Impact On Neurodegenerative And Autoimmune Diseases Treatments

Houston, Texas-based Coya Therapeutics Inc. (NASDAQ: COYA) has just taken a giant leap in making effective proprietary treatments focused on certain neurodegenerative and autoimmune diseases available to more patients, as it announced the expansion of its exclusive worldwide rights for the development and c

FTC Solar, Exagen And 2 Other Stocks Under $3 Insiders Are Aggressively Buying

The Dow Jones closed lower by over 300 points on Friday. Investors, meanwhile, focused on some notable insider trades. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.

Lisa Levin

Finanzas

Trimestral

Anual

Nombre

Ingresos Variación
Bruto Variación
EBITDA Variación
EBIT Variación
Beneficios Variación

Flujos de Caja

Flujo de Caja Operativo (TTM)

-6.50M

Flujo de Caja de Inversión (TTM)

-1.08M

Flujo de Caja de Financiación (TTM)

2.13M

Flujo de Caja Libre (TTM)

-7.59M

Gasto de Capital (TTM)

-1.09M

Cambio Neto en Efectivo (TTM)

-5.45M

Tendencia de los analistas

1

abr

1

may

1

jun

3

ago

2

oct

Compra

Mantener

Venta

Venta fuerte

Calificación de analistas

4.1

Compra

Compra fuerte

Compra

Mantener

Venta

Venta fuerte

Métricas de Valoración

Valor Empresarial

$189.20M

Relación P/E (TTM)

-

Relación P/E (FWD)

-

Relación PEG (TTM)

-

Relación P/S (TTM)

2.58

Relación P/B (TTM)

15.37

Rendimiento de Ganancias % (TTM)

-10.58%

Rendimiento de Ganancias % (FWD)

-7.10%

EV / EBITDA (TTM)

-

Precio / EBITDA (TTM)

-

Precio / Flujo de Caja Libre (TTM)

-

Valor Contable / Acción

$0.50

Deuda Empresarial

Deuda Total

$22.84M

Deuda a Largo Plazo

$22.32M

Emisión de Deuda a Largo Plazo (TTM)

$0

Reembolso de Deuda a Largo Plazo (TTM)

-$1.41M

Efectivo Total

$24.59M

Deuda a Capital

2.13

Emisión de Deuda (TTM)

-$1.41M

Reembolso de Deuda (TTM)

-$1.41M